Polyphenon E®, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis

Carcinogenesis

Volumn 35, Issue 4, 2014, Pages 828-839

  Rizzi, Federica ^a,b,c   Naponelli, Valeria ^a,b,c   Silva, Alessandro ^c   Modernelli, Alice ^a   Ramazzina, Ileana ^a,b,c   Bonacini, Martina ^a,c   Tardito, Saverio ^a   Gatti, Rita ^a,b   Uggeri, Jacopo ^a   Bettuzzi, Saverio ^a,b,c  

^a Department of Biomedicine Biotechnology and Translational Research ^*  (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; POLYPHENON E; PUMA PROTEIN; CATECHIN; DRUG DERIVATIVE; PRIMER DNA;

ANOIKIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IC 50; MALE; NECROPTOSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN CLEAVAGE; PROTEIN INDUCTION; UNFOLDED PROTEIN RESPONSE; UPREGULATION; APOPTOSIS; CELL DIVISION; ENDOPLASMIC RETICULUM; METABOLISM; NUCLEOTIDE SEQUENCE; TRANSFORMED CELL LINE; TUMOR CELL LINE;

ANOIKIS; APOPTOSIS; BASE SEQUENCE; CATECHIN; CELL DIVISION; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; DNA PRIMERS; ENDOPLASMIC RETICULUM; HUMANS;

EID: 84898636911     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt481     Document Type: Article

References (54)

1. Jemal, A. et al. (2010) Cancer statistics, 2010. Cancer J. Clin., 60, 277-300.
2. Bray, F. et al. (2010) Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur. J. Cancer, 46, 3040-3052.
3. Gupta, S. (2007) Prostate cancer chemoprevention: current status and future prospects. Toxicol. Appl. Pharmacol., 224, 369-376.
4. Caporali, A. et al. (2004) The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Carcinogenesis, 25, 2217-2224.
5. Gupta, S. et al. (2001) Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl Acad. Sci. USA, 98, 10350-10355.
6. Bettuzzi, S. et al. (2006) Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res., 66, 1234-1240.
7. Brausi, M. et al. (2008) Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update. Eur. Urol., 54, 472-473.
8. Johnson, J.J. et al. (2010) Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine, 17, 3-13.
9. Khan, N. et al. (2009) Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies. Nutr. Cancer, 61, 836-841.
10. Yang, C.S. et al. (2013) Cancer prevention by tocopherols and tea polyphenols. Cancer Lett., 334, 79-85.
11. Révész, K. et al. (2011) Tea flavan-3-ols as modulating factors in endoplasmic reticulum function. Nutr. Res., 31, 731-740.
12. Révész, K. et al. (2007) Glucuronide transport across the endoplasmic reticulum membrane is inhibited by epigallocatechin gallate and other green tea polyphenols. Int. J. Biochem. Cell Biol., 39, 922-930.
13. Davalli, P. et al. (2011) Chronic administration of green tea extract to TRAMP mice induces the collapse of Golgi apparatus in prostate secretory cells and results in alterations of protein post-translational processing. Int. J. Oncol., 39, 1521-1527.
14. Gamberucci, A. et al. (2006) Green tea flavonols inhibit glucosidase II. Biochem. Pharmacol., 72, 640-646.
15. Magyar, J.E. et al. (2009) Endoplasmic reticulum stress underlying the proapoptotic effect of epigallocatechin gallate in mouse hepatoma cells. Int. J. Biochem. Cell Biol., 41, 694-700.
16. Sang, S. et al. (2005) Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions. J. Agric. Food Chem., 53, 9478-9484.
17. Piyaviriyakul, S. et al. (2011) Anti-angiogenic activity and intracellular distribution of epigallocatechin-3-gallate analogs. Biol. Pharm. Bull., 34, 396-400.
18. Cussenot, O. et al. (1991) Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J. Urol., 146, 881-886.
19. Gazzola, G.C. et al. (1981) The cluster-tray method for rapid measurement of solute fluxes in adherent cultured cells. Anal. Biochem., 115, 368-374.
20. Rizzi, F. et al. (2009) Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cells. J. Cell. Physiol., 219, 314-323.
21. Rizzi, F. et al. (2008) A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. PLoS One, 3, e3617.
22. Livak, K.J. et al. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408.
23. Gatti, R. et al. (2008) Analysis of living cells grown on different titanium surfaces by time-lapse confocal microscopy. Micron, 39, 137-143.
24. Gatti, R. et al. (1998) Comparison of annexin V and calcein-AM as early vital markers of apoptosis in adherent cells by confocal laser microscopy. J. Histochem. Cytochem., 46, 895-900.
25. Degeorges, A. et al. (1995) Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalized PNT1 human prostate epithelial cell line. Int. J. Cancer, 62, 724-731.
26. Kaighn, M.E. et al. (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urol., 17, 16-23.
27. Davalli, P. et al. (2012) Anticancer activity of green tea polyphenols in prostate gland. Oxid. Med. Cell. Longev., 2012, 984219.
28. Adhami, V.M. et al. (2009) Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clin. Cancer Res., 15, 1947-1953.
29. McLarty, J. et al. (2009) Tea polyphenols decrease serum levels of prostatespecific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev. Res. (Phila)., 2, 673-682.
30. Choan, E. et al. (2005) A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach. Urol. Oncol., 23, 108-113.
31. Jatoi, A. et al. (2003) A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer, 97, 1442-1446.
32. Elbling, L. et al. (2005) Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. FASEB J., 19, 807-809.
33. Hastak, K. et al. (2005) Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. FASEB J., 19, 789-791.
34. Clarke, R. et al. (2012) Endoplasmic reticulum stress, the unfolded protein response, autophagy, and the integrated regulation of breast cancer cell fate. Cancer Res., 72, 1321-1331.
35. Wek, R.C. et al. (2007) Translational control and the unfolded protein response. Antioxid. Redox Signal., 9, 2357-2371.
36. Schewe, D.M. et al. (2009) Inhibition of eIF2alpha dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy. Cancer Res., 69, 1545-1552.
37. Harding, H.P. et al. (2000) Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell, 5, 897-904.
38. Hamanaka, R.B. et al. (2005) PERK and GCN2 contribute to eIF2alpha phosphorylation and cell cycle arrest after activation of the unfolded protein response pathway. Mol. Biol. Cell, 16, 5493-5501.
39. Ron, D. et al. (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol., 8, 519-529.
40. Oyadomari, S. et al. (2004) Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ., 11, 381-389.
41. Bernales, S. et al. (2006) Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol., 4, e423.
42. Kroemer, G. et al. (2010) Autophagy and the integrated stress response. Mol. Cell, 40, 280-293.
43. Mizushima, N. et al. (2007) How to interpret LC3 immunoblotting. Autophagy, 3, 542-545.
44. Klionsky, D.J. et al. (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy, 4, 151-175.
45. Armstrong, J.L. et al. (2010) Regulation of endoplasmic reticulum stressinduced cell death by ATF4 in neuroectodermal tumor cells. J. Biol. Chem., 285, 6091-6100.
46. Nishitoh, H. (2012) CHOP is a multifunctional transcription factor in the ER stress response. J. Biochem., 151, 217-219.
47. Galehdar, Z. et al. (2010) Neuronal apoptosis induced by endoplasmic reticulum stress is regulated by ATF4-CHOP-mediated induction of the Bcl-2 homology 3-only member PUMA. J. Neurosci., 30, 16938-16948.
48. Wei, M.C. et al. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science, 292, 727-730.
49. Li, J. et al. (2006) Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J. Biol. Chem., 281, 7260-7270.
50. Dudgeon, C. et al. (2008) Green tea and PUMA: a deadly combination? Cancer Biol. Ther., 7, 909-910.
51. Yu, J. et al. (2008) PUMA, a potent killer with or without p53. Oncogene, 27 (suppl. 1), S71-S83.
52. Delavallée, L. et al. (2011) AIF-mediated caspase-independent necroptosis: a new chance for targeted therapeutics. IUBMB Life, 63, 221-232.
53. Mihailidou, C. et al. (2010) CHOP-dependent regulation of p21/waf1 during ER stress. Cell. Physiol. Biochem., 25, 761-766.
54. Kreuzaler, P. et al. (2012) Killing a cancer: what are the alternatives? Nat. Rev. Cancer, 12, 411-424.